Next |
home / stock / egrx / egrx message board
Subject | By | Source | When |
---|---|---|---|
Fairly positive investor analysis for $EGRX found at | mcsharkey | investorshub | 03/18/2020 3:47:38 AM |
Eagle Pharmaceuticals to Discuss Fourth Quarter and Full | mcsharkey | investorshub | 02/21/2020 1:41:59 AM |
Good Day Sprycel, | mcsharkey | investorshub | 02/12/2020 2:39:02 AM |
Good Day. Any hope here? With | mcsharkey | investorshub | 02/11/2020 10:36:53 AM |
Well after 2 years they got the FDA | Sprycel | investorshub | 02/22/2019 1:11:51 PM |
They finally did it after 2 years: | Sprycel | investorshub | 02/22/2019 1:10:58 PM |
What is going on with this stock? Just | Denairo | investorshub | 04/03/2018 3:06:02 PM |
Scott Tariff on Biologics acquisition | Bickema | investorshub | 02/26/2018 7:05:24 PM |
http://investor.eagleus.com/press-release/eagle-pharmaceuticals-inc-reports-four | Bickema | investorshub | 02/26/2018 3:10:28 PM |
WIth a market cap of 880 million and | Bickema | investorshub | 02/13/2018 3:20:06 PM |
Have not been here in quite a while, | Denairo | investorshub | 02/12/2018 11:29:52 PM |
Dew how much of the 700 EV for | Bickema | investorshub | 12/11/2017 5:31:33 PM |
big news Only 40 mil market cap cash | make it happen | investorshub | 11/17/2017 4:05:25 PM |
Eagle Pharmaceuticals Announces Positive Results of Study Conducted | Bickema | investorshub | 09/05/2017 6:52:28 PM |
Suing the FDA for Bendeka's Orphan application was | GD | investorshub | 07/27/2017 3:26:53 PM |
Classic Scott Tarriff.... A typical salesman without situational | stugwins | investorshub | 07/27/2017 2:56:24 PM |
$EGRX receives CRL for Ryanodex in heatstroke: #msg-133316969. | DewDiligence | investorshub | 07/26/2017 4:37:18 PM |
Too hot to handle: Study shows Earth's killer | Bickema | investorshub | 06/19/2017 5:45:46 PM |
Class action lawsuit update | bio_fan | investorshub | 05/23/2017 4:39:50 PM |
Replacing a CFO is one of the biggest | W4 | investorshub | 05/17/2017 1:54:07 PM |
News, Short Squeeze, Breakout and More Instantly...
Eagle Pharmaceuticals Inc. Company Name:
EGRX Stock Symbol:
NASDAQ Market:
Eagle Pharmaceuticals Inc. Website:
WOODCLIFF LAKE, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that data from the Company’s Phase III trial demonstrating the sustained response of amisulpride for the rescue tr...
WOODCLIFF LAKE, N.J., April 12, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (the “Company”) today announced that it received a notice (the “Notice”) on April 8, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (...
GD Culture Group Limited (GDC) is expected to report for Q4 2023 Citizens Inc. Class A ($1.00 Par) (CIA) is expected to report for quarter end 2023-12-31 Escalade Incorporated (ESCA) is expected to report for Q4 2023 Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31...